Abcam Investor Relations Material
Latest events
H2 2022
Abcam
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Abcam plc
Access all reports
Abcam plc is a global provider of life science research tools, specializing in the development and marketing of reagents and tools essential for research in the life sciences sector. The company's extensive product range includes primary and secondary antibodies, immunoassay kits, cellular and biochemical assays, proteins and peptides, as well as products for cell and tissue imaging. Abcam serves a broad array of customers including researchers in academia, clinical labs, and pharmaceutical, biotech, and diagnostic companies. Abcam is headquartered in Cambridge, Cambridgeshire, UK, and its shares are listed on the Nasdaq.
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
đșđž United States